Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age

NCT03143101 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT03143101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03143101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Lead sponsor
MedImmune LLC
Phase
Phase 4
Overall status
Completed
Start date
May 8, 2017
Completion date
September 29, 2017
Enrollment
200 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, influenza